Healthcare >> CEO Interviews >> January 26, 2004

WILLIAM HUNTER – ANGIOTECH PHARMACEUTICALS INC (ANPI)

DR. WILLIAM L. HUNTER is President and Chief Executive Officer of Angiotech Pharmaceuticals, Inc. Dr. Hunter is a Founder and a member of its scientific and management teams. He has co-authored many peer- reviewed publications and abstracts, funded research grants and numerous patents and patent applications since 1992. Dr. Hunter is active in the Science Council of British Columbia and serves as a director of Vigil Health Management Inc., The Michael Smith Foundation for Health Research and as an Advisory Board member for the Biotechnology MBA Program at the University of Western Ontario's Ivey School of Business. Dr. Hunter received his BSc from McGill University, Montreal in 1985 and his MSc and MD from the University of British Columbia in 1989 and 1992, respectively. He has earned numerous awards including the 2002 BC Biotech Vision and Leadership Award, the 2001 Pacific Region Entrepreneur of the Year Award for Technology and Communications, British Columbia Science and Technology Award for Industrial Innovation, Business in Vancouver's Top 40 under 40, as well as the Caldwell Partners Canada's Top 40 under 40. Profile
TWST: Could you begin with a quick overview of Angiotech

Pharmaceuticals?

Mr. Hunter: The premise of the company is really quite straightforward.

We use traditional pharmaceutical agents to